Creation and regulation of iPS cells by small RNA and oligonucleotides
Sanford-Burnham Medical Research Institute
posted on 03/23/2010

Features
· Enhances IPS cell generation efficiency
· Can direct differentiation of IPS cells
Background
Induced pluripotent stem cells are very similar to embryonic stem cells and were originally generated by over expression of four nuclear reprogramming factors; Oct4, Sox2, Klf4 and cMyc. Many cell types have been confirmed to be reprogrammable; however, efficiencies are very low ranging from 0.01%- 0.2%. The mechanism of how primary fibroblasts are reprogrammed to an ES-like state is currently unknown despite repeated attempts to find small molecule reprogramming agents. The current invention is based on the discovery that microRNAs are involved during IPS induction and can be introduced at key stages to enhance induction efficiency.
Lead Inventor
Tariq Rana, Ph.D.
Selected References
Patent Information
Full title: Method for generation and regulation of IPS cells and compositions thereof
U.S. Patent/Application #: 61/260,330
Priority date: 11-11-2009
Foreign filing: tbd
Burnham ID: 10-12
Status
Available for license
File Number: 10-12/RANA*
This innovation currently is not available for online licensing. Please contact Glenn Dourado, M. Sc., MBA at Sanford-Burnham Medical Research Institute for more information.
Find more innovations
